Comparison of destabilizing activities of a well-known αβ-fibril destabilizer rifampicin with methylene blue for its usage in Alzheimer’s disease treatment by Dursun, Merve
 
 
 
 
 
TED ANKARA COLLEGE FOUNDATION  
PRIVATE HIGH SCHOOL 
 
 
Comparison of destabilizing activities of a well-known αβ-fibril destabilizer  
rifampicin with methylene blue for its usage in Alzheimer’s disease treatment 
 
BIOLOGY EXTENDED ESSAY 
 
 
 
      Supervisor:  Fuat İsmet ŞİŞMAN 
Name of Candidate: Merve DURSUN 
Candidate Number:  1129-052 
                  Word Count:  3987
MERVE DURSUN 
001129-052 
MAY 2013 
 
 
 
ABSTRACT 
The aim of this experiment was to determine whether methylene blue has a destabilizing 
effect on αβ-fibrils or not for the usage in Alzheimer’s disease treatment. So that this 
extended essay includes the comparison of the destabilizing effect of methylene blue with 
rifampicin which is a well-known αβ-fibril destabilizer. 
My research question was “Does the destabilizing effect of methylene blue on Aβ-fibril 
formation in vitro sufficient for its usage in the Alzheimer’s disease’s treatment compared to 
Rifampicin?” 
My hypothesis was “Methylene blue can destabilize Aβ-fibril formation which is a symptom 
of Alzheimer’s disease in vitro as much as Rifampicin.” 
In order to answer the research question and test the hypothesis, Ellman’s 
spectrophotometric method and thioflavin-t fluorometric method was used. Ellman’s 
spectrophotometric method was to calculate the IC50 value of methylene blue which will be 
used in the second part. Second part was the comparison of the fluorescence concentrations 
at the end of the 24th hour. Destabilizers at their IC50 values were put into bathtubs and the 
bathtubs were put into bacteriological incubator. At the end of the 24th hour tubes were put 
into fluorometer device and the fluorescence concentrations were measured. As 
fluorescence concentration is directly proportional with αβ-fibril formation this 
measurement gave the necessary data about the destabilizing activity of methylene blue and 
rifampicin. 
At the end of the 24th hour fluorescence concentrations in the tubes that contain methylene 
blue and rifampicin were close to each but t-test results showed that there is difference 
between them. After the calculation of percentage effects of the destabilizer, the difference 
was more observable: the effect of methylene blue was more compared to rifampicin. This 
gives hope about the treatment of Alzheimer’s disease but also brings new questions to 
investigate. 
Word count:287 
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INTRODUCTION 
4 years ago my grandfather diagnosed with Alzheimer’s disease. He comes and stays with us 
with regular time intervals for his doctor controls. We have a dog for two years now but he 
forgets it and in his every visit he is surprised because of it. Also there are some notes 
everywhere on post-its like “Don’t forget to extinguish the furnace!” or “Don’t forget to 
close the cover of the refrigerator!”.  So I did a research about Alzheimer Disease; I learned 
that there are some symptomatic treatment options and some drug mechanism tests are 
being done. 
To start with I got a complete definition; Alzheimer’s disease (AD) is a progressive 
neurodegenerative disease that occurs at hippocampus and cortex regions of the brain, 
associated with irreversible loss of neurons leading to deterioration in cognitive functions. It 
is characterized by memory loss; personality or behavioral disorders; difficulties in speaking, 
direction finding, decision making, thinking and interpreting.1 
As a summary of the work and research I had done, it can be said that Alzheimer’s disease is 
thought to occur at brain with three major modifications; 
- Loss of nerve cells, 
- Intercellular protein deposits consist of extremely 
phosphorylated tau proteins which stabilize 
microtubules, 
- Extracellular protein deposits which are called 
amyloid plaques which I will be mentioning as Aβ-
fibril formation in further parts. 2 
I learnt that although Alzheimer’s disease is one of the most studied diseases in recent years 
there is no effective treatment yet. There are some symptomatic treatment options and the 
most common way is the usage of cholinesterase inhibitors by maintaining acetylcholine 
levels since Alzheimer’s disease pathogenesis has been linked to a deficiency in the brain 
neurotransmitter acetylcholine.  
My research showed me that cholinesterases are widely distributed enzymes divided into 
two groups according to their substrate specificities and kinetic behaviors towards to their 
inhibitors.3 Butrylcholinesterase hydrolyze butrylcholine. Acetylcholinesterase hydrolyzes 
                                                          
1 Nussbaum R.L., Ellis C.E. Alzheimer’s Disease and Parkinson’s Disease. N Engl J Med., 348, 1356-1364, (2003) 
2 Robinson S.R., Bishop G.M., Aβ as bioflocculant: implications for the amyloid hypothesis of Alzheimer’s 
Disease. Neurobiol Aging, 23,1051-1072, (2002) 
3 Maurstad G., Prass M., Serpell L.C., Sikorski P. Dehydration stability of amyloid fibrils studied by AFM. Eur 
Biophys J. 38(8): 1135-40, (2009) 
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acetylcholine to acetic acid and choline. Hydrolysis of acetylcholine is a necessary reaction to 
allow a neuron to return to its resting state after activation. 
Experiments and research which have carried out until today exposed that new effective 
cholinesterase inhibitors are needed for Alzheimer’s Disease treatment since the treatment 
effect of those in use is modest and, there is evidence of wide variability in the outcomes 
reported. Moreover, there is no known Aβ-fibril destabilizing agent in use for Alzheimer’s 
Disease treatment yet.  
According to the information that I collected during my research, cholinesterase inhibitors 
are being used for Alzheimer’s disease treatment and I learnt that Methylene blue is one of 
the substances that can inhibit acetylcholinesterase. Methylene Blue is a dye for a number of 
different staining procedures in Biology recently shown to inhibit cholinesterases4 and my 
project aims to determine the inhibitory activity of methylene blue on cholinesterase and to 
investigate the destabilizing effect of this inhibitor on Aβ-fibril formation in vitro5. In case 
that my study demonstrates that methylene blue may inhibit the Aβ-fibril formation in vitro, 
methylene blue may be presented as a promising novel agent in Alzheimer’s disease 
treatment with dual effects as acetylcholinesterase inhibitor and an Aβ-fibril destabilizer. 
When the action mechanism of Alzheimer’s disease is thought, Methylene blue can inhibit 
the loss of nerve cells and also destabilize the extracellular protein deposits.  
Currently, there are more than 100 clinical trials being conducted for the treatment of 
Alzheimer’s disease and there is a thought that methylene blue can inhibit the 
acetylcholinesterase and Aβ-fibril formation in vitro so that it can be a new treatment 
option. I will try to support the idea that Methylene Blue can be used as an option in the 
treatment process of Alzheimer’s disease by a comparison of Methylene Blue with 
Rifampicin.   
Rifampicin is a semisynthetic compound derived from Amycolatopsis rifamycinica that is 
used in the treatment of a number of bacteria.6 Also it is a known Aβ-fibril destabilizer that is 
used in Alzheimer’s disease’s treatment. So I thought that comparing the destabilizing 
activity of Methylene Blue with Rifampicin will give an idea about the possibility of using 
Methylene Blue in Alzheimer’s disease’s treatment.  
                                                          
4Kucukkilinc Tuylu, T., Ozer, I. (2007), Multi-site inhibition of human plasma cholinesterase by cationic 
phenoxazine and phenothiazine dyes. Archives in Biochemistry and Biophysics, Volume 461, Issue 2, Pages 294-
298.  
5 In vitro studies are studies in experimental biology that are conducted using components of an organism that 
have been isolated from their usual biological context in order to permit a more detailed or more convenient 
analysis than can be done with whole organisms. 
“In Vıtro.” Wikipedia, The Free Encyclopedia 
http://en.wikipedia.org/wiki/In_vitro 
6Sensi P, Margalith P, Timbal MT (1959). "Rifomycin, a new antibiotic—preliminary report". Farmaco Ed Sci 14: 
146–147. 
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Therefore, my research question is “Does the destabilizing effect of methylene blue on Aβ-
fibril formation in vitro sufficient for its usage in the Alzheimer’s disease’s treatment 
compared to rifampicin?” 
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HYPOTHESIS 
As I search, there is no definite cure or treatment for Alzheimer’s disease so I believe that 
the main targets in the treatment process of those patients is to improve the life standards 
and maximize the operational performance by correcting their cognitive functioning, mood 
and behavior. 
As I mentioned in introduction, for symptomatic treatment of Alzheimer’s Disease, generally 
cholinesterase inhibitors are preferred to maintain acetylcholine level.  
The cholinesterase inhibitors donepezil hydrochloride, galantamine hydrobromide, and 
rivastigmine tartrate are the current mainstays of symptomatic treatment for patients with 
Alzheimer’s Disease. In clinical trials for all three agents, beneficial effects on standard 
measures of cognitive and global function have been observed in patients with mild to 
moderate Alzheimer’s Disease. Although none of the cholinesterase inhibitors has been 
approved for treatment of patients in advanced stages of Alzheimer’s Disease, all three 
agents have had beneficial cognitive effects among patients with less severe forms of the 
disease.7 
Methylene blue is one of the substances which can inhibit cholinesterase activity like the 
ones I have mentioned in the upper paragraph8 and this means that it may be used in 
symptomatic treatment of Alzheimer’s Disease but there is still no information about the 
effect of Methylene Blue on that Aβ-fibril formation. My project aims to show that Aβ-fibril 
formation which is another symptom of Alzheimer’s Disease may be inhibited by methylene 
blue in vitro. The comparison will be made with a well-known Aβ-fibril destabilizer, 
Rifampicin. 
Since Methylene Blue can inhibit acetylcholinesterase activity it is thought that it may also 
inhibit Aβ-fibril formation9. Therefore it can be hypothesized that methylene blue can 
destabilize the Aβ-fibril formation in vitro as much as rifampicin. 
 
 
                                                          
7 Jay M. Ellis, DO, Director, Neuroscience Research of the Berkshires, 100 Wendell Ave, 
Pittsfield 
http://www.jaoa.org/content/105/3/145.abstract  
8 Kucukkilinc Tuylu, T., Ozer, I. (2007), Multi-site inhibition of human plasma cholinesterase by cationic 
phenoxazine and phenothiazine dyes. Archives in Biochemistry and Biophysics, Volume 461, Issue 2, Pages 294-
298. 
9 Kucukkilinc Tuylu, T., Ozer, I. (2007), Multi-site inhibition of human plasma cholinesterase by cationic 
phenoxazine and phenothiazine dyes. Archives in Biochemistry and Biophysics, Volume 461, Issue 2, Pages 294-
298. 
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METHOD, DEVELOPMENT & PLANNING 
After deciding to work on 
Alzheimer’s Disease I talked to my 
grandfather’s doctors and they 
guided me to the Pharmacy 
Faculty of Hacettepe since the 
laboratory opportunities in there 
are the best. So I send an e-mail to 
the head of the department of 
biochemistry Gülberk Uçar which 
includes all the necessary 
information about me and the 
extended essay. I got a response 
telling that they can help me. So I 
went to a meeting to meet and talk 
the details with Gülberk Uçar, I learnt that I can use the laboratory and an expert pharmacist 
Tuba Tüylü Küçükkılınç can help me about my project.  
Then we had meetings with her and when I mentioned her about my project, she told me 
that thioflavin-T fluorometric method could be used for the comparison of the destabilizing 
activities of Methylene Blue and Rifampicin. After this I learnt that IC50 values of the 
substances must be used for this kind of comparison as a procedure. IC50 value is a measure 
of the effectiveness of a compound in inhibiting biological or biochemical function. This 
quantitative measure indicates how much of a particular drug or other substance (inhibitor) 
is needed to inhibit a given biological process (or component of a process, i.e. an enzyme, 
cell, cell receptor or microorganism) by half.10 So I decided to use a standard method to find 
the IC50 value of Methylene blue and my research showed that the Ellman’s 
spectrophotometric method is the most suitable way for me as methylene blue is a dye and 
this method gives the most accurate results on these kinds of substances 
Methylene blue, rifampicin, acetylcholinesterase, acetylthiocholine, 3-(N-morpholino) 
propanesulfonic acid (MOPS) and 5,5’-ditiobis-(2-nitrobenzoic acid) (DTNB) are obtained by 
marketing from the medical firm Sigma. 
As I learnt from her, the spectrophotometric method, which I will utilize in my experiment, is 
usually used for the experiments that include dyes such as Methylene Blue. The main 
principle of Ellman’s spectrophotometric method is to determine the change in the 
absorbance which is directly proportional with color change. So that, to provide a color 
                                                          
10 “IC50.” Wikipedia, The Free Encyclopedia 
http://en.wikipedia.org/wiki/IC50 
Figure 1: Laboratory of Faculty of Pharmacy of Hacettepe University 
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change in the bathtubs, Acetylthiocholine reacts with human acetylcholinesterase with the 
presence of 5,5’-dithio-bis-(2-nitrobenzoic acid), DTNB. DTNB is a substance that gives yellow 
color when it reacts with thiol so that human acetylcholinesterase will be made to react with 
acetylthiocholine instead of acetylcholine. This means that the absorbance will increase with 
the increasing reaction rate. The reaction must occur also in the presence of 3-(N-
morpholino)propanesulfonic acid, MOPS, too to keep the pH constant.  
There is more than one way to 
determine the inhibitory activity 
of Methylene Blue but 
spectrophotometric method is 
the more common one because 
of the easiness of its usage. Also 
it gives the data in a very short 
time and it is claimed to be that 
the data collected by this 
method is the most accurate 
one. Moreover, a peltier-
equipped Shimadzu 1601 PC 
Spectrophotometer, keeps the 
internal temperature constant 
at desired value during the 
measurement.  
As the standard procedure, Methylene 
Blue activity is observed by using three 
different concentrations and a control 
group. While adjusting the three 
different concentrations of Methylene 
Blue criteria is to take three values that 
are not close to each other to get a 
more accurate best line for the graph. 
Then the collected data will be used to 
draw a graph and the equation of the 
best line of the graph will be used to 
find IC50 value of Methylene Blue. IC50 
value of Rifampicin is 100µM. 11 
                                                          
11 Kucukkilinc Tuylu, T., Ozer, I. (2007), Multi-site inhibition of human plasma cholinesterase by cationic 
phenoxazine and phenothiazine dyes. Archives in Biochemistry and Biophysics, Volume 461, Issue 2, Pages 294-
298. 
Figure 2: Peltier-equipped Shimadzu 1601 PC Spectrophotometer 
 
Figure 3: Inside of Peltier-equipped Shimadzu 1601 PC 
Spectrophotometer 
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After these, thioflavin-T fluorometric method 
will be used to compare the destabilizing 
activities of Rifampicin and Methylene Blue. 
The main principle of thioflavin-T fluorometric 
method is to measure the fluorescence at a 
certain moment so that it can be used at 
experiments which include fluorescence 
change. Fluorescence is the emission of light 
by a substance that has absorbed light or 
other electromagnetic radiation.12 As 
Methylene blue or Rifampicin destabilizes Aβ-
fibril formation fluorescence value will decrease because of the decreasing light emission of 
the plaques. To make the reaction occur NaCl (sodium chloride) will put into the test tubes 
and to stabilize the pH at high levels MKB (mono basic potassium phosphate, KH2PO4) will be 
added. 
Making the measurement at 0th, 2nd, 6th and 
24th hours will give the opportunity to 
calculate and compare the fluorescence 
changes in three test groups. (Control group, 
Rifampicin group, Methylene Blue group) 
Destabilization of Aβ-fibrils cause a 
fluorescence change so that the thioflavin-T 
fluorometric method is preferred. Measuring 
the fluorescence change at 0th, 2nd, 6th and 24th 
hours will give the needed data to draw a 
second graph to compare the effects of 
Rifampicin and Methylene Blue. Also there must be a control group which does not contain 
any inhibitor to see the inhibitor activity. Between the two measurements, bathtubs must be 
incubated at 370C which is the natural human body temperature. 13 
Furthermore, the primary reason why I have chosen these two methods is that these 
methods will provide me quantitative data that I need to compare Methylene blue with 
Rifampicin. Although there are more ways to get the needed data, I preferred these two 
methods because making the measurements with these devices are easy to learn and use. At 
the same time these two methods are two of the methods that give the most accurate data 
as I learnt from the experts at the laboratory. 
                                                          
12 “Fluorescence.” Wikipedia, The Free Encyclopedia 
http://en.wikipedia.org/wiki/Fluorescense 
13 Normal temperature is about 37°C or 98.6°F. 
http://www.healthcare-online.org/Normal-Body-Temperature.html  
Figure 4: Fluorometer device 
 
Figure 5: Inside of fluorometer device 
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MATERIAL LIST 
 
10000 µL  3-(N-morpholino)propanesulfonic acid, (MOPS) 
10500 µL  H2O 
2000 µL  5,5’-dithio-bis-(2-nitrobenzoic acid), (DTNB) 
2000 µl  Acetylthiocholine, (ATC) 
200 µL  Human acetylcholinesterase, (AChE) (Sigma) 
25 µL   25µM Methylene Blue, (MB) (Sigma) 
150 µL  5µM Methylene Blue, (MB) (Sigma) 
10 µL   0.125µM Methylene Blue, (MB) (Sigma) 
3000 µL  Aβ-fibril (Sigma) 
7500 µL  100µM Mono basic potassium phosphate 
– MKB, (KH2PO4) 
1500 µL  1000µM Sodium chloride, (NaCl) 
50 µL   10µM Rifampicin (Sigma) 
×25   Bathtubs (1×1×2cm3) 
×1   1000 µL micropipette 
×1  200 µL micropipette 
×1  20 µL micropipette 
 
Refrigerator 
Bacteriological incubator 
Peltier-equipped Shimadzu 1601 PC 
Spectrophotometer 
Fluorometer device 
Figure 6: Materials that are used in the experiment 
(inside the refrigerator) 
Figure 7: Materials that are used in the experiment 
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METHOD 
A)  CALCULATION OF IC50 VALUE OF METHYLENE BLUE  
(ELLMAN’S SPECTROPHOTOMETRIC METHOD) 14,15 
 
1) To create a control group; put the substances below into 5 bathtubs. 
 -500 µL MOPS, 
-390 µL water, 
-100 µL ATC 
-100 µL DTNB 
-10 µL AChE  
2) Put the substances below into other 15 bathtubs.   
-500 µL MOPS, 
-370 µL water, 
-100 µL ATC 
-100 µL DTNB 
-10 µL AChE   
 
3)  -Add 5µL 25µM methylene blue into 5 of those 20. (to have 125nM finally) 
-Add 15µL 5µM methylene blue into 5 of those 20. (to have 75nM finally) 
-Add 2µL 0.125µM methylene blue 5 of those 20. (to have 0.25nM finally) 
4) Measure the absorbance values with a Peltier-equipped Shimadzu 1601 PC 
Spectrophotometer. 
5)  Draw a graph by using the measured absorbance values and calculate IC50 value by 
using the equation of the best line of the graph. 
                                                          
14 See Appendix 3 
15 See Appendix 4 
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B)  MEASURING FLOURESCENCES OF THE SOLUTIONS CONTAINING 
DIFFERENT DESTABLISERS  
(THIOFLAVIN-T FLUOROMETRIC METHOD) 16 
 
1) To create a control group; put the substances below into 5 bathtubs. 
-200 µL Aβ-fibril 
-190 µL water, 
-500 µL 100 µM KP 
-100 µL 1000 µM NaCl 
 
2) Put the substances below into other 10 bathtubs.  
-200 µL Aβ-fibril 
-190 µL water, 
-500 µL 100 µM KP 
-100 µL 1000 µM NaCl 
 
3)  - Add 10µL 10µM Rifampicin into 5 of those 10. (to have 100nM finally) 
 - Add 14µL 5µM Methylene blue 5 of those 10. (to have 70nM finally) 
 
4) Measure the fluorescence values with the fluorometer device. 
5) Record the data (initial fluorescence concentration) 
5) Put the bathtubs into the bacteriological incubator and adjust the temperature to 370C. 
6) Measure the fluorescence values at 2nd, 6th and 24th hours with the fluorometer device. 
7) Record the data. 
                                                          
16 See Appendix 5 
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DATA COLLECTION AND PROCESSING 
 
 
 FLUORESCENCE CONCENTRATION(±0.001µM) 
TYPE OF 
DESTABLIZER 
NO DESTABLIZER 
(CONTROL GROUP) 
RIFAMPICIN METHYLENE BLUE 
TRIAL 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 
TIME 
(HOUR) 
0 0.135 0.136 0.136 0.135 0.133 0.168 0.165 0.166 0.166 0.165 0.161 0.159 0.158 0.159 0.158 
2 0.824 0.822 0.821 0.821 0.822 0.160 0.160 0.159 0.160 0.161 0.162 0.163 0.162 0.163 0.160 
6 0.937 0.935 0.935 0.936 0.937 0.032 0.034 0.033 0.032 0.034 0.039 0.041 0.041 0.040 0.039 
24 0.932 0.936 0.935 0.933 0.934 0.048 0.045 0.046 0.045 0.046 0.040 0.041 0.038 0.038 0.038 
Table 1: Table 1 shows the fluorescence concentrations at the beginning and at the end of the 2nd, 6th and 24th hours in 5 trials which are 
measured to check that the destabilizers are working.
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After these measurements to observe the change more clearly average fluorescence 
concentrations are calculated by using the method below: 
 
 
Where; 
 is fluorescence concentration 
 in  is trial number  
 
Example calculation: 
(Average fluorescence concentration calculation for  
time=2 hours and 
destabilizer= methylene blue) 
 
 
 
 
AVERAGE FLUORESCENCE 
CONCENTRATION (±0.001µM) 
TYPE OF 
DESTABLIZER 
NO 
DESTABLIZER 
(CONTROL 
GROUP) 
RIFAMPICIN 
METHYLENE 
BLUE 
TIME 
(HOUR) 
0 0.135 0.166 0.159 
2 0.822 0.160 0.162 
6 0.936 0.033 0.040 
24 0.934 0.046 0.039 
Table 2: Table 2 shows the average fluorescence concentrations at the beginning and at the 
ends of  2nd, 6th and 24th hours.
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TYPE OF 
DESTABLIZER 
TRIAL 
FLUORESCENCE 
CONCENTRATION 
(±0.001µM) 
TOTAL 
TIME 
(hour) 
TYPE 
OF 
FIBRIL 
VOLUME 
OF FIBRIL 
(±0.05µL) 
VOLUME 
OF KP 
(±0.05µL) 
CONCENTRATION 
OF KP 
(µM) 
VOLUME 
OF NaCl 
(±0.05µL) 
CONCENTRATION 
OF NaCl 
(µM) 
VOLUME 
OF H2O 
(±0.05µL) 
TYPE 
OF 
WATER 
FINAL 
CONCENTRATION 
OF DESTABLIZER 
(nM) 
WAITING 
TEMPERATURE 
(±0.050C) 
Methylene 
blue 
1 0.040 
24 
Aâ-
fibril 
(mark: 
Sigma) 
200.00 500.00 100 100.00 1000 190.00 
Pure 
water 
70 
(IC50 value) 
37.00 
2 0.038 
3 0.038 
4 0.041 
5 0.038 
AVERAGE 0.039 
Rifampicin 
1 0.048 
24 
Aâ-
fibril 
(mark: 
Sigma) 
200.00 500.00 100 100.00 1000 190.00 
Pure 
water 
100 
(IC50 value) 
37.00 
2 0.046 
3 0.045 
4 0.046 
5 0.045 
AVERAGE 0.046 
No destabilizer 
(Control group) 
1 0.932 
24 
Aâ-
fibril 
(mark: 
Sigma) 
200.00 500.00 100 100.00 1000 190.00 
Pure 
water 
- 37.00 
2 0.934 
3 0.935 
4 0.933 
5 0.936 
AVERAGE 0.934 
Table 3: Table 3 shows the fluorescence concentrations in the bathtubs which contain different destabilizers (Rifampicin and Methylene Blue) 
at their IC50 values when Sigma marked  200 µL Aβ-fibril, 500 µL 100 µM KP, 100 µL 1000 µM NaCl, 190 µL pure water are used and the waiting 
temperature is constant at 370C. 
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Table 4: Table 4 shows the fluorescence values in the bathtubs after 24 hours with the 
mean, mode, median, range, variance, standard deviation, standard error, t and 95% 
confidence values of the collected data. 
FLOURESCENCE CONCENTRATION (µM) 
 INHIBITOR TYPE 
TRIAL 
- 
(CONTROL 
GROUP) 
RIFAMPICIN 
METHYLENE 
BLUE 
1 0.932 0.048 0.040 
2 0.936 0.045 0.041 
3 0.935 0.046 0.038 
4 0933 0.045 0.038 
5 0.934 0.046 0.038 
 
   
MEAN OF THE 
FLOURESCENCE 
0.934 0.046 0.039 
MODE  -  0.045 0.039 
MEDIAN 0.934 0.046 0.039 
RANGE 0.004 0.003 0.003 
VARIANCE 0.000 0.000 0.000 
SD 0.002 0.001 0.001 
SE 0.001 0.001 0.001 
t 2.776 2.776 2.776 
%95CI 
(SE X T(0,05,df) 
0.002 0.002 0.002 
%95CI 
(EXEL) 
0.001 0.001 0.001 
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Table 5: t-test: two sample for means of the fluorescence concentrations in the bathtubs 
that contain one of methylene blue or rifampicin at the end of 24th hour. 
 
P value (written in bold) is smaller than 0.05 and this means that there is a difference 
between two groups. 
t-Test: Two Sample for Means  
  
 
 
  Variable 1 Variable 2 
Average 0.046 0.039 
Variance 0.0000015 0.000002 
Observation 5 5 
Pearson Correlation 0.144337567  
Estimated Average Difference 0  
Df 4  
t Stat 9.036961141  
P(T<=t) one-tailed 0.000415322  
t Critical one-tailed 2.131846782  
P(T<=t) two-tailed 0.000830645  
t Critical two-tailed 2.776445105 
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To see the difference; with a simple calculation percentage effect of destabilizer on 
fluorescence concentration can be found: 
 
Where; 
 is percentage effect of destabilizer 
is fluorescence concentration 
 
Example calculation: 
(for methylene blue) 
 
 
 
 
 
 
TYPE OF DESTABLIZER 
PERCENTAGE EFFECT OF 
DESTABILIZER ON FLUORESCENCE 
CONCENTRATION (%) 
NO DESTABLIZER (CONTROL GROUP) +591.852 
RIFAMPICIN -72.289 
METHYLENE BLUE -75.472 
Table 6: Percentage effect of the destabilizer at the end of the 24th hour where “-“ means 
decrease in fluorescence concentration and “+” means increase in fluorescence 
concentration. 
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Graph 1: Graph 1 shows the change in the fluorescence concentrations in the tube due to 
time and destabilizer effect where the blue line is for control group (which includes no 
destabilizer), red line is for rifampicin and green line is for methylene blue. 
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Graph 2: Graph 2 shows the average fluorescence concentrations in the bathtubs that 
contains rifampicin or methylene blue or none of them (control group) at the end of the 24th 
hour. 
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CONCLUSION AND EVALUATION 
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that occurs at 
hippocampus and cortex regions of the brain, associated with irreversible loss of neurons 
leading to deterioration in cognitive functions. 17 One of the major modifications that 
Alzheimer’s disease causes is extracellular protein deposits (αβ-fibril formation). 
As there is no known Aβ-fibril destabilizer agent that can be used for Alzheimer’s disease 
treatment yet, this experiment was about testing the destabilizing activity of Methylene blue 
for its usage in Alzheimer’s disease’s treatment in the way that it can destabilize Aβ-fibril 
formation and also inhibit acetylcholinesterase. 
In this experiment my aim was to show that Methylene blue can destabilize Aβ-fibril 
formation like Rifampicin (a well-known Aβ-fibril destabilizer which cannot be used in 
Alzheimer’s disease treatment because of several reasons). To prove my hypothesis I used 
Ellman’s Spectrophotometric method and thioflavin-T fluorometric method. Ellman’s 
spectrophotometric method was to find the IC50 value of Methylene blue and thioflavin-T 
method was to measure the fluorescence concentration change which is directly related 
with Aβ-fibril presence. 
200 µL Aβ-fibril, 190 µL water, 500 µL 100 µM KP and 100 µL 1000 µM NaCl were put into 
bathtubs and rifampicin or methylene blue is added to tubes. The fluorescence 
concentration was measured by a fluorometer device and data is recorded. Measurements 
were made at the beginning and at the ends of the 2nd, 6th and 24th hours to check if the 
destabilizers are working.  
Table 1 contains the results that are obtained in trials and table 2 shows the calculated 
average values to see the pattern easily. In the control group which does not include any of 
the destabilizers the fluorescence concentration increases from the beginning to the end of 
the 6th hour. At the beginning fluorescence concentration is 0.135µM; it becomes 0.822µM 
at the end of 2nd hour and 0.936µM at the end of 6th hour. This shows that the αβ-fibril 
formation occurs. Also in the first two hours, the fluorescence concentration increases 
0.687µM which means that the formation rate is high in the first two hours when there is no 
destabilizer. On the other hand fluorescence concentrations in the tubes that contain one of 
the two destabilizers (methylene blue or rifampicin) decrease with time. Fluorescence 
concentration in the rifampicin containing tube is 0.166µM at the beginning. It becomes 
0.160µM and 0.033µM as time passes. Fluorescence concentration in methylene blue 
containing tube increases 3µM in the first two hours but then it decreases to 0.040µM. This 
shows that both of the destabilizers, did destabilize the formation of αβ-fibril but the small 
increase in the methylene blue containing tube means that the methylene blue becomes 
                                                          
17 Nussbaum R.L., Ellis C.E. Alzheimer’s Disease and Parkinson’s Disease. N Engl J Med., 348, 1356-1364, (2003) 
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more active with the time unlike rifampicin. At the end of the 24th hour, fluorescence 
concentration in the control group is almost same with the value at the end of the 6th hour 
(0.934µM). This proves the presence of Aβ-fibril. The increase in the fluorescence 
concentration in rifampicin containing tube shows that the destabilizer becomes less 
affective after a time between the 6th and 12th hour. On the other hand it can be seen that 
the fluorescence concentration in methylene blue containing tubes are decreased between 
the 6th and 12th hours; it becomes 0.039µM. This means that the effect of methylene blue is 
still continuing. 
Graph 1 was for visualizing the data obtained and given in table 2. In the graph it can be seen 
that the fluorescence concentration in control group bath tubes is increasing rapidly 
whereas the fluorescence concentrations of the other tubes which include rifampicin or 
methylene blue is decreasing. (Where increase in the fluorescence means increase in 
emission of fibrils and increase in emission of fibril means increase in volume of fibril 
whereas the decrease means the opposites.) Moreover, it is observable that the 
fluorescence concentration values in the tubes containing methylene blue or rifampicin are 
close to each other.  
In graph 2 the fluorescence concentrations at the end of the 24th hour is compared. In graph 
2 it can be seen that the fluorescence concentrations in the tubes that contain rifampicin 
and in the ones that include methylene blue are really close to each other. This shows that 
the destabilizing activity of methylene blue and rifampicin are close to each other. On the 
other hand it is not possible make a detailed comparison of the destabilizing activity of 
rifampicin and methylene blue by just looking the average results at the end of the 24th hour. 
Table 3 shows the fluorescence concentrations in the bathtubs at the end of the 24th hour 
with the details of the trials. The fluorescence concentrations in the tubes that contain 
rifampicin are 0.048 µM, 0.046 µM, 0.045 µM, 0.046 µM, 0.045 µM whereas the 
concentration is tubes containing methylene blue are 0.040, 0.038, 0.038, 0.041, 0.038µM. 
To compare the destabilizing activity of rifampicin and methylene blue collected data is 
analyzed by making a t-test. Although they look similar in the previous graphs and tables, p 
value is 0.000830645 which is smaller than 0.05 giving the result that they differ from each 
other. 
To decide which was more effective at the end of the 24th hour percentage effects of the 
destabilizers are calculated. Percentage effect of methylene blue is -75.472%. This means 
that methylene blue decreased the formation of αβ-fibril by 75.472% with respect to the 
beginning. Percentage effect of rifampicin is -72.289%. This percentages show that 
methylene blue was more effective at the end of the 24th hour and this shows that 
methylene blue is a good destabilizer. 
These results give a positive thought and hope for the treatment of Alzheimer’s disease. 
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On the other hand there were some errors: 
1) First of all, to check if the experiment is working or not the bathtubs were taken out 
from the Bacteriological incubator at the end of the 2nd and 6th hours in which the 
temperature is stabilized at 370C. So that the change in the temperature might have 
affected the results. 
2) Secondly, when Table 2 is observed carefully, it can be seen that the fluorescence 
concentration at the end of 2nd and 6th hour in bathtubs that contain rifampicin is less 
than the ones contain methylene blue. This means that Rifampicin destabilized more 
in the first 6 hours. But when we look at the results that is collected at the end of 24th 
hour fluorescence concentration in the tubes that contain methylene blue is less. This 
means that rifampicin is more active in the first two hours and methylene blue is 
more active after a point after 6th hour. (Rifampicin is no longer affective after a 
point after the 6th hour.) 
3) When using spectrophotometer or fluorometer, transparency and cleaning of the 
tubes are the factors that affect the results. Although same tubes are used and the 
conditions were same for all trials, tubes were put into devices with gloves and this 
might have caused a decrease in transparency a little. 
 
For further investigation on this subject and further applications of this experiment there are 
a few things that can be done to improve the experiment. 
 
1) Six trials for each destabilizer should be made. In this way, 6th tube will be taken out 
to check if the experiment is working and that tubes will not be used for getting 
results. 
2) 24th hour is not the best time to compare the destabilizing activity as the effect of 
rifampicin decreases earlier. Getting the results at the end of the 8th or 9th hour will 
be better to see the fluorescence concentrations when the effects of the destabilizer 
are at maximum level. 
3) For not touching the tubes before the measurements to be sure that there is no 
decrease in transparency, tubes can be filled in the spectrophotometer/fluorometer 
after cleaning them carefully. 
 
As a similar experiment has not performed before there is no quantitative data to compare 
the results. Further studies will give the opportunity to compare the results and to comment 
on them. Although this results give hope about the treatment of Alzheimer’s disease in the 
way that methylene blue can destabilize the αβ-fibril formation, later studies on this should 
test the availability of methylene blue in treatment of Alzheimer’s disease in humans by 
looking for the side effects and trying to reduce them. 
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APPENDIX 1  
UNITS 
PREFIX SYMBOL 10n EXAMPLE 
yotta Y 1024 1YM=1024M 
zetta Z 1021 1ZM=1021M 
exa E 1018 1EM=1018M 
peta P 1015 1PM=1015M 
tera T 1012 1TM=1012M 
giga G 109 1GM=109M 
mega M 106 1MM=106M 
kilo k 103 1kM=103M 
hector h 102 1hM=102M 
deca da 101 1daM=101M 
  100 1M 
deci d 10-1 1dM=10-1M 
centi c 10-2 1cM=10-2M 
milli m 10-3 1mM=10-3M 
micro µ 10-6 1µM=10-6M 
nano n 10-9 1nM=10-9M 
pico p 10-12 1pM=10-12M 
femto f 10-15 1fM=10-15M 
atto a 10-18 1aM=10-18M 
zepto z 10-21 1zM=10-21M 
yocto y 10-24 1yM=10-24M 
Table 7: units 
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APPENDIX 2 
ABBREVIATIONS & SYMBOLS 
 
AD: Alzheimer’s disease 
MOPS: 3-(N-morpholino) propanesulfonic acid 
DTNB: 5-5’-dithio-bis-(2-nitrobenzenoic acid)/ also known as Ellman’s reagent 
ATC: Acetylthiocholine 
AChE: Acetylcholinesterase 
MB: Methylene blue 
KP: Potassium phosphate 
NaCl: Sodium chloride 
ThT: Thioflavin-t 
 
µM: micro molar 
nM: nano molar 
µL: micro liter 
cm3: cubic centimeter 
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APPENDIX 3:  
SPECTROPHOTOMETRIC METHOD & ABSORBANCE 
 
Spectrophotometry is the quantitative measurement of the reflection or transmission 
properties of a material as a function of wavelength.18 
Spectrophotometry involves the use of a spectrophotometer. A spectrophotometer is a 
photometer that can measure intensity as a function of the light source wavelength. 
Important features of spectrophotometers are spectral bandwidth and linear range of 
absorption or reflectance measurement.19 
The sequence of events in a modern spectrophotometer is as follows: 
1. The light source is imaged upon the sample 
2. A fraction of the light is transmitted or reflected from the sample 
3. The light from the sample is imaged upon the entrance slit of the monochromator 
4. The monochromator separates the wavelengths of light and focuses each of them 
onto the photodetector sequentially. 
 
 
 
                                                          
18 Allen, D., Cooksey, C., & Tsai, B. (2010, October 5). Spectrophotometry. Retrieved from 
http://www.nist.gov/pml/div685/grp03/spectrophotometry.cfm  
19 “Spectrophotometry.” Wikipedia, The Free Encyclopedia 
http://en.wikipedia.org/wiki/Spectrophotometry 
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As DTNB (Ellman’s reagent) is used in the experiment, special name of the method is 
Ellman’s spectrophotometric method. 
In spectroscopy, the absorbance of a material is a logarithmic ratio of the radiation falling 
upon a material, to the radiation transmitted through a material.20 21 
Absorbance is the fraction of radiation absorbed at a specific wavelength.22 It can be 
calculated by Beer-Lambert Law. 
Beer-Lambert Law relates the absorption of light to the properties of the material through 
which the light is travelling.23 
 
Where;  
 is absorbance,  
Ɛ is the molar absorptivity  
 is the path length of the sample - the path length of the bathtub in which the sample is 
contained.  
 is the concentration of the compound in solution 
In the experiment;  
Ɛ is stabilized at 14.2 mM-1cm-1 by the spectrophotometer.  
 is stabilized by using the bathtubs that are identical ( =1cm) 
So that the absorbance depends on . 
AChE reacts with ACT and produces thiol which DTNB reacts with to produce yellow color. 
The inhibitor (in this case MB) inhibits the reaction of AChE with ATC, so that the production of 
yellow color is decreases; absorbance decreases. (  in this case is the concentration of the 
substance with yellow color which is produced when DTNB reacted with thiol) 
                                                          
20 Mehta, A. UV-Visible Spectroscopy- Derivation of Beer-Lambert Law 
21 "Dictionary — Definition of absorptance". Websters-online-dictionary.org. http://www.websters-online-
dictionary.org/ab/absorptance.html. Retrieved 2011-11-21. 
22“Absorbance.” Wikipedia, The Free Encyclopedia 
 http://en.wikipedia.org/wiki/Absorbance 
23 “Beer Lambert Law.” Wikipedia, The Free Encyclopedia 
http://en.wikipedia.org/wiki/Beer%E2%80%93Lambert_law 
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APPENDIX 4: CALCULATION OF IC50 VALUE 
The half maximal inhibitory concentration (IC50) is a measure of the effectiveness of a 
compound in inhibiting biological or biochemical function. This quantitative measure 
indicates how much of a particular drug or other substance (inhibitor) is needed to inhibit a 
given biological process by half.24 
In this experiment IC50 value of MB refers to the concentration which MB can inhibit the 
reaction of AChE by 50%. 
To calculate the IC50 value three concentrations of MB were put into the bathtubs that 
contain MOPS, water, ATC, DTNB and AChE. 
 
Final concentration of MB is calculated by using the formula below: 
 
Where; 
M1 is the concentration in the first solution, 
V1 is the volume of the first solution, 
M2 is the concentration in the final solution, 
V2 is the volume of the final solution. 
 
5 of the tubes contain 5µL 25µM MB,  
 
 
 
5 of the tubes contain 15µL 5µM MB, 
 
 
                                                          
24 “IC50.” Wikipedia, The Free Encyclopedia 
http://en.wikipedia.org/wiki/IC50 
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5 of the tubes contain 2µL 0.125µM MB. 
 
 
Then the bathtubs were put into spectrophotometer and the change in absorbance is 
measured. As absorbance is directly proportional with the color change, absorbance also 
gives the activity of AChE. The concentration where the activity is 50% gives the IC50 value of 
MB. 
 
 ACTIVITY (ABSORBANCE) 
CONCENTRATION OF 
MB (nM) 
TRIAL 1 TRIAL 2 TRIAL 3 MEAN 
CONTROL 
GROUP 
125 0.0215 0.0226 0.0215 0.0219 0.1312 
75 0.0185 0.0164 0.0153 0.0167 0.0453 
0.25 0.0283 0.0228 0.0270 0.0260 0.0287 
Table 8: Shows the absorbance values in the test tubes. Control groups are the ones which 
do not include inhibitor and the absorbance in the control groups change because of the 
decrease in the enzyme activity due to time. 
Percentage activity is calculated by using the formula below: 
 
 
CONCENTRATION OF MB 
(nM) 
%ACTVITY 
125 16.7% 
75 36.9% 
0.25 98.6% 
Table 9: Shows the calculated %activity of MB in different concentrations. 
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 Graph 3: Graph 3 shows the %activity of methylene blue when it is not used or used in 
different concentrations (0.125nM, 75nM, 125nM). 
As the wanted activity of MB is 50%, 50 is put instead of y in the equation of the best line. 
 
 
 
 
 
 
 
As the IC50 value of MB is found to be 68.97.. which is close to 70nM, 70 nM MB will be used 
in the second part of the experiment. 
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APPENDIX 5: THIOFLAVIN-T FLUOROMETRIC METHOD 
Fluorometry is an analytical technique for identifying and characterizing minute amounts of 
a substance by excitation of the substance with a beam of ultraviolet light and detection and 
measurement of the characteristic wavelength of fluorescent light emitted.25 
Fluorometry has been firmly established as method for the sensitive, specific and economic 
detection of trace quantities of substances. Generally, a fluorometric method has the 
potential of being 10—100 fold more sensitive than a colorimetric procedure, since dyes 
have a molar absorptivity of i05.' By coupling a fluorometric read-out with a catalytic or a 
non-stoichiometric chemical process even greater enhanced sensitivity may be achieved. 
The greatly improved fluorometric instrumentation becoming commercially available for 
automated analyses has further contributed to the increasing utility of fluorometry in such 
diverse applications as environmental pollution, clinical chemistry, biology and metallurgy. 
Criteria for the choice of a set of reaction conditions for use in fluorometry include: rapid 
rates, fluorescent product stability, lack of internal quenching, and a highly fluorescent 
product.26 
αβ-fibrils are obtained commercially which means that are solved in 0.02% ammonia 
solution. It is known that when these αβ-fibrils are mixed with NaCl, MKB, and H2O; and 
made to stay in a bacteriological incubator at 370C a typical fluorescence is observed27. So 
that putting NaCl, MKB and H2O is the standard procedure to measure the fluorescence 
concentration in the tubes that contain αβ-fibrils. 
 
 
                                                          
25 http://medical-dictionary.thefreedictionary.com/fluorometry 
26 http://www.seminarsonly.com/Chemical_Engineering/Fluorometric_Analytical_Methods.php 
27 Kucukkilinc Tuylu, T., Ozer, I. (2007), Multi-site inhibition of human plasma cholinesterase by cationic 
phenoxazine and phenothiazine dyes. Archives in Biochemistry and Biophysics, Volume 461, Issue 2, Pages 294-
298.  
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